# Lisata Therapeutics, Inc.: filings

LSTA · Nasdaq · CIK 320017 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lsta.md) · [Financials](/companies/lsta/financials.md) · [Filings](/companies/lsta/filings.md) · [Insiders](/companies/lsta/insiders.md)

## Reports and events: 390 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 502, 8-K 269, 10-Q 53, 3 48, 424B5 31, CORRESP 31, DEFA14A 25, EFFECT 24, UPLOAD 23, S-8 19, 10-K 18, S-3 17, 425 16, DEF 14A 15, SC 13G 13, 424B3 11, SC 13G/A 11, 10-K/A 9, 8-K/A 9, D 9, SC14D9C 9, SC 13D/A 8, 424B2 6, S-4/A 6, PRE 14A 5, 3/A 4, S-1/A 4, S-4 4, S-8 POS 4, SC 14D9/A 4, 4/A 3, S-3/A 3, SC TO-C 3, SC TO-T/A 3, 10-Q/A 2, ARS 2, CT ORDER 2, S-1 2, SC TO-T 2, 25 1, 25-NSE 1, 424B1 1, 8-A12B 1, AW 1, CERTNAS 1, DEFM14A 1, FWP 1, NT 10-K 1, NT 10-Q 1, POS AM 1, PREM14A 1, RW 1, RW WD 1, SC 13D 1, SC 14D9 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 10:38 ET | [DEF 14A](/filings/0001140361-26-039986.md) | Proxy statement, period 2026-11-09 | 0001140361-26-039986 |
| 2026-10-14 | 20:25 ET | [8-K](/filings/0001140361-26-039602.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-039602 |
| 2026-09-17 | 13:27 ET | [8-K](/filings/0001140361-26-036866.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036866 |
| 2026-08-06 | 20:03 ET | [10-Q](/filings/0000320017-26-000038.md) | Quarterly report, period 2026-06-30 | 0000320017-26-000038 |
| 2026-08-04 | 10:01 ET | [8-K](/filings/0001140361-26-031028.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-031028 |
| 2026-07-24 | 16:15 ET | [8-K](/filings/0001140361-26-029541.md) | 1.02 Termination of a material agreement; 8.01 Other events | 0001140361-26-029541 |
| 2026-07-17 | 11:01 ET | [8-K](/filings/0001140361-26-028763.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-028763 |
| 2026-06-09 | 11:30 ET | [8-K](/filings/0001140361-26-024560.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-024560 |
| 2026-06-01 | 10:03 ET | [8-K](/filings/0001140361-26-023397.md) | 8.01 Other events | 0001140361-26-023397 |
| 2026-05-29 | 20:50 ET | [8-K](/filings/0001140361-26-023336.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-023336 |
| 2026-05-11 | 20:03 ET | [10-Q](/filings/0000320017-26-000032.md) | Quarterly report, period 2026-03-31 | 0000320017-26-000032 |
| 2026-05-04 | 10:04 ET | [8-K](/filings/0001140361-26-018651.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-018651 |
| 2026-04-28 | 20:03 ET | [10-K/A](/filings/0000320017-26-000028.md) | Annual report, amended, period 2025-12-31 | 0000320017-26-000028 |
| 2026-04-15 | 20:01 ET | [8-K](/filings/0001140361-26-014775.md) | 8.01 Other events | 0001140361-26-014775 |
| 2026-04-03 | 00:42 ET | [8-K](/filings/0001140361-26-013070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-013070 |
| 2026-03-12 | 20:07 ET | [10-K](/filings/0000320017-26-000023.md) | Annual report, period 2025-12-31 | 0000320017-26-000023 |
| 2026-03-09 | 11:39 ET | [8-K](/filings/0000320017-26-000020.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-26-000020 |
| 2026-02-27 | 21:00 ET | [8-K](/filings/0000320017-26-000012.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000320017-26-000012 |
| 2026-01-27 | 13:27 ET | [8-K](/filings/0000320017-26-000008.md) | 8.01 Other events | 0000320017-26-000008 |
| 2026-01-21 | 13:58 ET | [8-K](/filings/0000320017-26-000006.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-26-000006 |
| 2025-11-06 | 21:16 ET | [10-Q](/filings/0000320017-25-000070.md) | Quarterly report, period 2025-09-30 | 0000320017-25-000070 |
| 2025-11-06 | 21:10 ET | [8-K](/filings/0000320017-25-000069.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000069 |
| 2025-10-14 | 20:02 ET | [8-K](/filings/0000320017-25-000066.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000066 |
| 2025-10-08 | 19:12 ET | [8-K](/filings/0000320017-25-000063.md) | 1.01 Entry into a material agreement | 0000320017-25-000063 |
| 2025-08-07 | 20:13 ET | [10-Q](/filings/0000320017-25-000060.md) | Quarterly report, period 2025-06-30 | 0000320017-25-000060 |
| 2025-08-07 | 20:09 ET | [8-K](/filings/0000320017-25-000059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000059 |
| 2025-07-15 | 12:00 ET | [8-K](/filings/0000320017-25-000048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-25-000048 |
| 2025-06-26 | 12:38 ET | [8-K](/filings/0000320017-25-000043.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000043 |
| 2025-06-17 | 13:13 ET | [8-K](/filings/0000320017-25-000039.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000039 |
| 2025-06-13 | 20:02 ET | [8-K](/filings/0000320017-25-000037.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000320017-25-000037 |
| 2025-06-10 | 20:03 ET | [8-K](/filings/0000320017-25-000033.md) | 5.07 Shareholder vote results | 0000320017-25-000033 |
| 2025-05-08 | 20:14 ET | [10-Q](/filings/0000320017-25-000030.md) | Quarterly report, period 2025-03-31 | 0000320017-25-000030 |
| 2025-05-08 | 20:07 ET | [8-K](/filings/0000320017-25-000028.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000028 |
| 2025-04-25 | 20:10 ET | [DEF 14A](/filings/0000320017-25-000023.md) | Proxy statement, period 2025-04-25 | 0000320017-25-000023 |
| 2025-02-27 | 21:10 ET | [10-K](/filings/0000320017-25-000011.md) | Annual report, period 2024-12-31 | 0000320017-25-000011 |
| 2025-02-27 | 21:06 ET | [8-K](/filings/0000320017-25-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000010 |
| 2025-01-23 | 21:02 ET | [8-K](/filings/0000320017-25-000004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-25-000004 |
| 2024-12-03 | 13:33 ET | [8-K](/filings/0000320017-24-000061.md) | 1.01 Entry into a material agreement | 0000320017-24-000061 |
| 2024-11-12 | 21:10 ET | [10-Q](/filings/0000320017-24-000058.md) | Quarterly report, period 2024-09-30 | 0000320017-24-000058 |
| 2024-11-12 | 21:08 ET | [8-K](/filings/0000320017-24-000057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000057 |
| 2024-08-12 | 20:21 ET | [10-Q](/filings/0000320017-24-000051.md) | Quarterly report, period 2024-06-30 | 0000320017-24-000051 |
| 2024-08-12 | 20:08 ET | [8-K](/filings/0000320017-24-000049.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000049 |
| 2024-06-27 | 20:53 ET | [8-K](/filings/0000320017-24-000034.md) | 2.02 Results of operations | 0000320017-24-000034 |
| 2024-05-09 | 20:13 ET | [10-Q](/filings/0000320017-24-000031.md) | Quarterly report, period 2024-03-31 | 0000320017-24-000031 |
| 2024-05-09 | 20:08 ET | [8-K](/filings/0000320017-24-000029.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000029 |
| 2024-04-29 | 20:51 ET | [DEF 14A](/filings/0000320017-24-000016.md) | Proxy statement, period 2024-04-29 | 0000320017-24-000016 |
| 2024-04-17 | 20:04 ET | [8-K](/filings/0000320017-24-000013.md) | 5.02 Departure or appointment of officers or directors | 0000320017-24-000013 |
| 2024-02-29 | 21:12 ET | [10-K](/filings/0000320017-24-000007.md) | Annual report, period 2023-12-31 | 0000320017-24-000007 |
| 2024-02-29 | 21:09 ET | [8-K](/filings/0000320017-24-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000006 |
| 2023-11-02 | 20:11 ET | [10-Q](/filings/0000320017-23-000063.md) | Quarterly report, period 2023-09-30 | 0000320017-23-000063 |

Page 1 of 8. [Older](/companies/lsta/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.